Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
Aralez Pharmaceuticals Inc. (ARLZ)
|
|
Operating Efficiency |
|
|
|
|
Annual |
|
In millions, except per share items | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 |
| Source | Source | Source | Source | Source | Source |
Turnover Ratios |
Inventory turnover | 8.5 | 10.7 | | | | |
Asset turnover | 0.2 | 0.2 | 0.0 | 0.0 | | |
|
Returns on Capital |
ROIC (excluding intangibles) | | | -0.9% | | | |
ROIC (including intangibles) | -17.3% | -24.4% | 482.2% | 0.2% | 124.1% | |
ROE | -407.2% | -81.5% | -254.6% | 0.0% | -93.5% | |
ROA | -13.7% | -18.8% | -116.7% | 0.0% | -47.1% | |
|
Cash Conversion Cycle |
Days sales outstanding | 46.3 | 137.2 | 101.8 | 63,427.2 | | |
Days payables outstanding | 180.3 | 132.4 | | 14,005.3 | | |
Days inventory outstanding | 50.7 | 68.2 | | | | |
Cash conversion cycle | -83.3 | 73.0 | | 49,421.9 | | |
|